A University of Queensland (UQ) research team led by Professor Darryl Eyles has developed a novel intranasal formulation of clozapine that could transform the treatment of schizophrenia.
Antipsychotic drugs, like clozapine, can stabilise some schizophrenia symptoms, but they do not cure the illness and can cause severe side effects. QBI's Professor Darryl Eyles and Dr Xiaoying Cui are investigating a new delivery mode for clozapine.
Svetlina Vasileva, a PhD student in the Eyles lab, has led a study to explore associations between the composition of the gut microbiome, schizophrenia and its treatment.
A new study has found newborns with vitamin D deficiency have a 44 per cent increased risk of being diagnosed with schizophrenia as adults compared to those with normal vitamin D levels.
